| Short Description : | Recombinant-Cynomolgus TNFSF7/CD27 Ligand/CD70-N-His protein was developed in hek293 cells using the region Gln39-Pro194. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 1 EU/Mu g of the protein by LAL method. |
| Immunogen: | Recombinant Cynomolgus TNFSF7/CD27 Ligand/CD70 Protein is produced by Expi293 cells expression system. The target protein is expressed with sequence (Gln39-Pro194) of Cynomolgus TNFSF7 (Accession # G7PYU6-1) fused with His tag at the N-terminus. |
| Immunogen Region: | Gln39-Pro194 |
| Background | CD70, also named CD27 ligand (CD27L) , is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and has been designated TNFSF7.? CD70 is a cytokine that binds to CD27. Plays a role in T-cell activation. Induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells. |
Information sourced from Uniprot.org
